CAS 123021-85-2

{4-[(E)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy}acetic acid

CAS: 123021-85-2

Formel: C₁₂H₉NO₅S

Reinheit: 97%

Molekulargewicht: 279.2686

Ref: IN-DA01KCO5

GPR35 agonist 3

CAS: 123021-85-2

GPR35 agonist 3

Reinheit: ≥98%

Molekulargewicht: 279.27g/mol

Ref: 54-BUP08332

GPR35 Agonist, Compound 10

CAS: 123021-85-2

Formel: C₁₂H₉NO₅S

Molekulargewicht: 279.27

Ref: 7W-GK3754

GPR35 Agonist, compound 10

CAS: 123021-85-2

GPR35 Agonist, compound 10 is a novel G protein-coupled receptor (GPCR) agonist that has been shown to have strong anti-inflammatory properties. It is capable of reducing the severity of meningoencephalitis and can also be used to treat mycoses, such as fungal infections. This drug is synthesized by cloning a gene encoding for GPR35 into a vector and expressing it in bacteria. The recombinant protein is then purified from this bacterial culture.

Formel: C₁₂H₉NO₅S

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 279.27 g/mol

Ref: 3D-BG178579

GPR35 agonist 3

CAS: 123021-85-2

GPR35 agonist 3 is a synthetic GPR35 agonist used in the study of cancer, type 2 diabetes and cardiovascular disease.

Formel: C₁₂H₉NO₅S

Reinheit: 98.80%

Farbe und Form: Solid

Molekulargewicht: 279.27

Ref: TM-T72755